StoneX Group Inc.

Position in ABBV — AbbVie Inc.

CIK 913760 New York, NY

Position in ABBV

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$8,230,389

+$2,049,324 QoQ

Shares Held

32,707

+15.1% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.84%

of 13F equity value

Holder Rank

#1,022

of 4,153 holders

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

StoneX Group Inc. holds $35,939,835 across 13 Drug Manufacturers - General names. ABBV ranks #1 (22.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc. This page	32,707	$8,230,389
2	LLY	ELI LILLY & Co	6,635	$7,958,218
3	JNJ	Johnson & Johnson	27,201	$6,908,237
4	MRK	Merck & Co., Inc.	42,565	$5,469,602
5	AMGN	Amgen Inc	12,416	$4,496,081
6	PFE	Pfizer Inc	33,470	$805,957
7	BMY	Bristol Myers Squibb Co	9,503	$547,562
8	NVS	Novartis AG	2,818	$441,636

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,230,389	32,707	+15.1%	Shares	Defined	2026-08-12
2026-03-31	$6,181,065	28,420	-39.1%	Shares	Defined	2026-05-14
2025-12-31	$10,666,598	46,683	+3.2%	Shares	Defined	2026-02-12
2025-09-30	$10,471,628	45,226	-4.1%	Shares	Defined	2025-11-14
2025-06-30	$8,753,467	47,158	+157.4%	Shares	Defined	2025-08-13
2021-09-30	$1,976,070	18,319	-0.3%	Shares	Defined	2021-10-20
2021-06-30	$2,069,309	18,371	+8.4%	Shares	Defined	2021-08-06
2021-03-31	$1,834,220	16,949	+5.9%	Shares	Defined	2021-06-30
2020-12-31	$1,714,507	16,001	+4.9%	Shares	Defined	2021-02-03
2020-09-30	$1,336,623	15,260	+10.8%	Shares	Defined	2020-11-12
2020-06-30	$1,351,644	13,767	+10.8%	Shares	Defined	2020-08-12
2020-03-31	$946,584	12,424	—	Shares	Defined	2020-04-30
No filing history on record for this holder in this stock.